Wanbury Limited Cash Flow Conversion Efficiency

Latest as of September 2025: -0.053x

Wanbury Limited cash flow conversion efficiency. Based on the latest financial reports, Wanbury Limited (WANBURY) has a cash flow conversion efficiency ratio of -0.053x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-56.53 Million ≈ $-611.33K USD) by net assets (Rs1.07 Billion ≈ $11.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Wanbury Limited (2006–2025)

Cash flow conversion efficiency of Wanbury Limited from 2006 to 2025. This chart illustrates how Wanbury Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Wanbury Limited stock price for real-time trading data and today's change.

Wanbury Limited Cash Flow Conversion Ratio Explained

Wanbury Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Wanbury Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wanbury Limited ranked by their cash flow conversion efficiency. Also see Wanbury Limited stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Unitech Electronics Co. Ltd.
TW:3652
-0.005x
Holland Colours NV
AS:HOLCO
-0.010x
Metrofile
JSE:MFL
0.237x
Recce Pharmaceuticals Ltd
AU:RCE
-0.020x
Arena Group Holdings Inc
NYSE MKT:AREN
-2.718x
SKY E&M Co. Ltd
KQ:131100
0.027x
Selectquote Inc
NYSE:SLQT
0.074x
Mordechai Aviv Taasiot Beniyah 1973 Ltd
TA:AVIV
-0.019x

Annual Cash Flow Conversion Efficiency for Wanbury Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Wanbury Limited from 2006 to 2025. Review WANBURY free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs592.72 Million
≈ $6.41 Million
Rs261.02 Million
≈ $2.82 Million
0.440x +209.30%
2024-03-31 Rs279.41 Million
≈ $3.02 Million
Rs39.78 Million
≈ $430.23K
0.142x +123.60%
2023-03-31 Rs-328.16 Million
≈ $-3.55 Million
Rs197.97 Million
≈ $2.14 Million
-0.603x +65.13%
2022-03-31 Rs-234.20 Million
≈ $-2.53 Million
Rs405.23 Million
≈ $4.38 Million
-1.730x -1520.63%
2021-03-31 Rs-1.56 Billion
≈ $-16.90 Million
Rs166.81 Million
≈ $1.80 Million
-0.107x +65.30%
2020-03-31 Rs-1.43 Billion
≈ $-15.51 Million
Rs441.33 Million
≈ $4.77 Million
-0.308x -116.56%
2019-03-31 Rs-2.09 Billion
≈ $-22.63 Million
Rs297.31 Million
≈ $3.22 Million
-0.142x +18.93%
2018-03-31 Rs-1.85 Billion
≈ $-19.97 Million
Rs323.65 Million
≈ $3.50 Million
-0.175x +38.09%
2017-03-31 Rs-1.53 Billion
≈ $-16.58 Million
Rs433.86 Million
≈ $4.69 Million
-0.283x -7.32%
2016-03-31 Rs-1.63 Billion
≈ $-17.65 Million
Rs430.53 Million
≈ $4.66 Million
-0.264x -16.35%
2015-03-31 Rs-1.77 Billion
≈ $-19.16 Million
Rs401.67 Million
≈ $4.34 Million
-0.227x +17.67%
2014-03-31 Rs-1.65 Billion
≈ $-17.85 Million
Rs454.48 Million
≈ $4.92 Million
-0.275x +92.09%
2013-03-31 Rs-212.95 Million
≈ $-2.30 Million
Rs741.21 Million
≈ $8.02 Million
-3.481x -980.07%
2012-03-31 Rs711.13 Million
≈ $7.69 Million
Rs281.25 Million
≈ $3.04 Million
0.395x +747.00%
2011-03-31 Rs1.05 Billion
≈ $11.35 Million
Rs49.02 Million
≈ $530.13K
0.047x -78.40%
2010-03-31 Rs1.92 Billion
≈ $20.81 Million
Rs416.05 Million
≈ $4.50 Million
0.216x -52.49%
2009-03-31 Rs1.58 Billion
≈ $17.13 Million
Rs720.95 Million
≈ $7.80 Million
0.455x +318.55%
2007-03-31 Rs1.29 Billion
≈ $13.96 Million
Rs-268.83 Million
≈ $-2.91 Million
-0.208x -346.01%
2006-03-31 Rs1.01 Billion
≈ $10.94 Million
Rs-47.21 Million
≈ $-510.60K
-0.047x --

About Wanbury Limited

NSE:WANBURY India Drug Manufacturers - Specialty & Generic
Market Cap
$72.39 Million
Rs6.69 Billion INR
Market Cap Rank
#20280 Global
#1117 in India
Share Price
Rs191.59
Change (1 day)
+0.56%
52-Week Range
Rs163.34 - Rs344.75
All Time High
Rs344.75
About

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines,… Read more